Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haifeng Song

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Cell Research|March 23, 2016
CCAR1 5' UTR as a natural miRancer of miR-1254 overrides tamoxifen resistanceGaopeng Li, Xiaoli Wu, Wenchang Qian, et al.
International Journal of Toxicology|June 2, 2022
Repeated-Dose Toxicity, Biodistribution, and Shedding Assessments With a ChAd155 Respiratory Syncytial Virus Vaccine Candidate Evaluated in Rabbits and RatsAlan H Stokes, Camille Planty, Johanne Pion, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 2, 2024
A Phase I Clinical Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of GB221 Injection and Trastuzumab (Herceptin<sup>®</sup>) in Healthy Chinese AdultsYu Zhu, Chen Li, Liming Chen, et al.
Frontiers in Pharmacology|July 5, 2022
A Randomized Controlled Dose-Escalation Study of LY06006, a Recombinant Humanized Monoclonal Antibody to RANKL, in Chinese Healthy AdultsSuping Niu, Min Chen, Diqin Yan, et al.
The Journal of Clinical Investigation|January 14, 2009
Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathwayLihua Ding, Zhaoyun Wang, Jinghua Yan, et al.
NPJ Vaccines|July 26, 2022
Rational development of a combined mRNA vaccine against COVID-19 and influenzaQing Ye, Mei Wu, Chao Zhou, et al.
Journal of Hematology & Oncology|January 16, 2019
Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patientsBixia Tang, Xieqiao Yan, Xinan Sheng, et al.
Alternatives to Laboratory Animals : ATLA|October 8, 2009
An immunologic model for rapid vaccine assessment -- a clinical trial in a test tubeRussell G Higbee, Anthony M Byers, Vipra Dhir, et al.
Precision Clinical Medicine|June 13, 2022
The SARS-CoV-2 spike L452R-E484Q variant in the Indian B.1.617 strain showed significant reduction in the neutralization activity of immune seraGen Li, Zhongcheng Zhou, Peng Du, et al.
Nature Medicine|April 24, 2019
A safe and potent anti-CD19 CAR T cell therapyZhitao Ying, Xue F Huang, Xiaoyu Xiang, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Cell Research|March 23, 2016
CCAR1 5' UTR as a natural miRancer of miR-1254 overrides tamoxifen resistanceGaopeng Li, Xiaoli Wu, Wenchang Qian, et al.
International Journal of Toxicology|June 2, 2022
Repeated-Dose Toxicity, Biodistribution, and Shedding Assessments With a ChAd155 Respiratory Syncytial Virus Vaccine Candidate Evaluated in Rabbits and RatsAlan H Stokes, Camille Planty, Johanne Pion, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 2, 2024
A Phase I Clinical Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of GB221 Injection and Trastuzumab (Herceptin<sup>®</sup>) in Healthy Chinese AdultsYu Zhu, Chen Li, Liming Chen, et al.
Frontiers in Pharmacology|July 5, 2022
A Randomized Controlled Dose-Escalation Study of LY06006, a Recombinant Humanized Monoclonal Antibody to RANKL, in Chinese Healthy AdultsSuping Niu, Min Chen, Diqin Yan, et al.
The Journal of Clinical Investigation|January 14, 2009
Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathwayLihua Ding, Zhaoyun Wang, Jinghua Yan, et al.
NPJ Vaccines|July 26, 2022
Rational development of a combined mRNA vaccine against COVID-19 and influenzaQing Ye, Mei Wu, Chao Zhou, et al.
Journal of Hematology & Oncology|January 16, 2019
Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patientsBixia Tang, Xieqiao Yan, Xinan Sheng, et al.
Alternatives to Laboratory Animals : ATLA|October 8, 2009
An immunologic model for rapid vaccine assessment -- a clinical trial in a test tubeRussell G Higbee, Anthony M Byers, Vipra Dhir, et al.
Precision Clinical Medicine|June 13, 2022
The SARS-CoV-2 spike L452R-E484Q variant in the Indian B.1.617 strain showed significant reduction in the neutralization activity of immune seraGen Li, Zhongcheng Zhou, Peng Du, et al.
Nature Medicine|April 24, 2019
A safe and potent anti-CD19 CAR T cell therapyZhitao Ying, Xue F Huang, Xiaoyu Xiang, et al.
Pageof 16